COVID-19 Convalescent Plasma Trials

UPenn’s Katharine Bar discusses ongoing clinical trials to explore the efficacy of treating patients with plasma from individuals who have recovered from an infection.

The Scientist Staff

Aug 18, 2020

Read the full story.

Related Articles

NIH Halts Outpatient COVID-19 Convalescent Plasma Trial

NIH Halts Outpatient COVID-19 Convalescent Plasma Trial

NIH Halts Outpatient COVID-19 Convalescent Plasma Trial

Inhaled Antibody Fragments Protect Infected Animals Against COVID-19

Inhaled Antibody Fragments Protect Infected Animals Against COVID-19

Inhaled Antibody Fragments Protect Infected Animals Against COVID-19

SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C

SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C

SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C

Labs Worldwide Still Struggling Amid Broken Supply Chains

Labs Worldwide Still Struggling Amid Broken Supply Chains

Labs Worldwide Still Struggling Amid Broken Supply Chains